These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36161317)

  • 1. Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Oh S; Suzuki K
    Interact Cardiovasc Thorac Surg; 2022 Nov; 35(6):. PubMed ID: 36161317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
    Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer.
    Hattori A; Takamochi K; Matsunaga T; Fukui M; Suzuki K
    Interdiscip Cardiovasc Thorac Surg; 2023 Nov; 37(5):. PubMed ID: 37738593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentectomy versus lobectomy for small-sized pure solid non-small cell lung cancer.
    Li Z; Xu W; Pan X; Wu W; Chen L
    Thorac Cancer; 2023 Apr; 14(11):1021-1028. PubMed ID: 36882365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes.
    Roman M; Labbouz S; Valtzoglou V; Ciesla A; Hawari M; Addae-Boateng E; Thorpe JA; Duffy JP; Majewski A
    Eur J Surg Oncol; 2019 May; 45(5):845-850. PubMed ID: 30409440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ground glass opacity resection extent assessment trial
    Li H; Wang Y; Chen Y; Zhong C; Fang W
    Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
    Ann Thorac Surg; 2022 Apr; 113(4):1317-1324. PubMed ID: 34022215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
    Aokage K; Suzuki K; Saji H; Wakabayashi M; Kataoka T; Sekino Y; Fukuda H; Endo M; Hattori A; Mimae T; Miyoshi T; Isaka M; Yoshioka H; Nakajima R; Nakagawa K; Okami J; Ito H; Kuroda H; Tsuboi M; Okumura N; Takahama M; Ohde Y; Aoki T; Tsutani Y; Okada M; Watanabe SI;
    Lancet Respir Med; 2023 Jun; 11(6):540-549. PubMed ID: 36893780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
    Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
    Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm.
    Kamigaichi A; Tsutani Y; Kagimoto A; Fujiwara M; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2020 Nov; 21(6):e528-e538. PubMed ID: 32482526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    Chan EG; Chan PG; Mazur SN; Normolle DP; Luketich JD; Landreneau RJ; Schuchert MJ
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1639-1648.e2. PubMed ID: 32331817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
    Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
    Kamigaichi A; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2019 Sep; 20(5):397-403.e1. PubMed ID: 31281050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1245-1253. PubMed ID: 32893296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.